Outcomes of intensive care for patients with human immunodeficiency virus infection

Archives of Internal Medicine

Volumn 160, Issue 4, 2000, Pages 541-547

  Nichas, Gigi ^a,b,c   Wachter, Robert M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Pacific Coast Physicians Inc   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; SERUM ALBUMIN;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTENSIVE CARE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROLOGIC DISEASE; PRIORITY JOURNAL; RESPIRATORY FAILURE; SEPSIS; SURVIVAL; TREATMENT OUTCOME;

EID: 0034723763     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.160.4.541     Document Type: Article

References (27)

1. Critical care medicine. JAMA. 1983;250:798-804.
2. Bayer R, Callahan D, Fletcher J, et al. The care of the terminally ill: mortality and economics. N Engl J Med. 1983;309:1490-1494.
3. Schneiderman LJ, Jecker NS, Jonsen AR. Medical futility: its meaning and ethical implications. Ann Intern Med. 1990;112:949-954.
4. Hammer SM, Katzenstein DA, Hughes MD, et al, for the AIDS Clinical Trials Group 175 Study Team. A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. N Engl J Med. 1996;335:1081-1090.
5. The Delta Coordinating Committee. Delta: a randomized double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals. Lancet. 1996;348:283-291.
6. Collier AC, Coombs RW, Schoenfeld DA, et al, for the AIDS Clinical Trials Group. Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. N Engl J Med. 1996;334:1011-1017.
7. Hammer SM, Squires KE, Hughes MD, et al, for the AIDS Clinical Trials Group 320 Study Team. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Med. 1997;337:725-733.
8. Wachter RM, Luce JM, Turner J, Volberding P, Hopewell PC. Intensive care of patients with the acquired immunodeficiency syndrome: outcome and changing patterns of utilization. Am Rev Respir Dis. 1986;134:891-896.
9. Wachter RM, Russi MB, Bloch DA, Hopewell PC, Luce JM. Pneumocystis carinii pneumonia and respiratory failure in AIDS: improved outcomes and increased use of intensive care units. Am Rev Respir Dis. 1991;143:251-256.
10. Wachter RM, Luce JM, Safrin S, Berrios DC, Charlebois E, Scitovsky AA. Cost and outcome of intensive care for patients with AIDS, Pneumocystis carinii pneumonia, and severe respiratory failure. JAMA. 1995;273:230-235.
11. el-Sadr W, Simberkoff MS. Survival and prognostic factors in severe Pneumocystis carinii pneumonia requiring mechanical ventilation. Am Rev Respir Dis. 1988;137:1264-1267.
12. Efferen LS, Nadarajah D, Palat DS. Survival following mechanical ventilation for Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome: a different perspective. Am J Med. 1989;87:401-404.
13. Franklin C, Freidman Y, Wong T, Hu TC. Improving long-term prognosis for survivors of mechanical ventilation in patients with AIDS with PCP and acute respiratory failure: five-year follow-up of intensive care unit discharges. Arch Intern Med. 1995;155:91-95.
14. Rosen MJ, Clayton K, Schneider RF, et al, and the Pulmonary Complication of HIV Infection Study Group. Intensive care of patients with HIV infection: utilization, critical illnesses, and outcomes. Am J Respir Crit Care Med J. 1997;155:67-71.
15. DePalo VA, Millstein BH, Mayo PH, Salzman SH, Rosen MJ. Outcome of intensive care in patients with HIV infection. Chest. 1995;107:506-510.
16. Lazard T, Retel O, Guidet B, Maury E, Valleron AJ, Offenstadt G. AIDS in a medical intensive care unit: immediate prognosis and long-term survival. JAMA. 1996; 276:1240-1245.
17. Casalino E, Mendoza-Sassi G, Wolff M, et al. Predictors of short-and long-term survival in HIV-infected patients admitted to the ICU. Chest. 1998;113:421-429.
18. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. J. 1985;13:818-829.
19. Centers for Disease Control and Prevention. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep. 1992;41(RR-17):1-19.
20. Kaplan EL, Meier P. Non-parametric estimations from incomplete observations. J Am Stat Assoc. 1958;53:175-181.
21. Schein RM, Fischl MA, Pitchenik AE, Sprung CL, et al. ICU survival of patients with the acquired immunodeficiency syndrome. Crit Care Med. 1986;14:1026-1027.
22. Rosen MJ, Cucco RA, Teirstein AS. Outcome of intensive care in patients with the acquired immunodeficiency syndrome. J Intensive Care Med. 1986;1:55-60.
23. Rogers PL, Lane HC, Henderson DK, Parillo J, Masur H. Admission of AIDS patients to a medical intensive care unit: causes and outcome. Crit Care Med. 1989; 17:113-117.
24. Bedos JP, Chastang C, Lucet JC, Kalo T, Gachot B, Wolff M. Early predictors of outcome for HIV patients with neurologic failure. JAMA. 1995;273:35-40.
25. Gulick RM, Mellors JW, Havlir D, et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med. 1997;337:734-739.
26. Havlir DV, Marschner IC, Hirsch MS, et al, for the AIDS Clinical Trials Group Study 343 Team. Maintenance with antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy. N Engl J Med. 1998;339: 1261-1268.
27. Curtis JR, Bennett CL, Horner RD, Rubenfeld GD, DeHovitz JA, Weinstein RA. Variations in intensive care utilization for patients with human immunodeficiency virus-related Pneumocystis carinii pneumonia: importance of hospital characteristics and geographic location. Crit Care Med. 1998;26:668-675.